EU antitrust regulators will examine Illumina Inc's proposed $7.1 billion acquisition of cancer test maker Grail Inc, the European Commission said on Tuesday, following a request from six countries on competition concerns.
from Gadgets Now https://ift.tt/3dxgVqK
No comments:
Post a Comment